ASPG and acute lymphoblastic leukemia: The context of that study was to investigate the genetic basis for allergic reactions which occur in up to 45% of patients receiving asparaginase derived from Escherichia coli or Erwinia chrysanthemi for treatment of childhood acute lymphoblastic leukemia.